References
Hewes J, Morris R, Hutchins R, Bhattacharya S and Davison B. Preoperative Chemotherapy and the Outcome of Liver Resection for Colorectal Metastases. World J Surg (DOI: 10.1007/s00268-006-0103-8)
Fusai G, Davidson BR. Management of colorectal liver metastases. Colorectal Dis 2003;5:2–23
Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P,Engerran L. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509–520
Bilchik AJ, Poston G, Curley SA, Strasberg S, Saltz L, Adam R, Nordlinger B,Rougier P, Rosen LS. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 2005;23:9073–9078
Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065–2072
Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005;200:845–853
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Espat, N.J. Is There an Increased Negative Outcome for Hepatic Resection following Pre-operative Chemotherapy?. World J. Surg. 31, 365–366 (2007). https://doi.org/10.1007/s00268-006-0753-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-006-0753-6